Genpact Shares Up 23.4% Since SmarTrend's Buy Recommendation (G)
Comtex SmarTrend(R) - Thu Feb 12, 4:47PM CST
SmarTrend identified an Uptrend for Genpact (NYSE:G) on October 31st, 2014 at $17.48. In approximately 3 months, Genpact has returned 23.37% as of today's recent price of $21.57.
G: 21.48 (-0.09)
21.0% Return Seen to Date on SmarTrend Genpact Call (G)
Comtex SmarTrend(R) - Thu Feb 05, 11:13AM CST
SmarTrend identified an Uptrend for Genpact (NYSE:G) on October 31st, 2014 at $17.48. In approximately 3 months, Genpact has returned 21.00% as of today's recent price of $21.15.
G: 21.48 (-0.09)
Genpact's (G) CEO Tiger Tyagarajan on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 04, 11:56PM CST
G: 21.48 (-0.09)
Genpact Limited (G) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Feb 04, 3:25PM CST
G: 21.48 (-0.09)
Genpact beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 3:06PM CST
G: 21.48 (-0.09)
Genpact Reports Results for 2014 Full Year and Fourth Quarter
PR Newswire - Wed Feb 04, 3:01PM CST
Genpact Limited (NYSE: G), a global leader in designing, transforming, and running intelligent business operations, today announced financial results for the fourth quarter and full year ended December 31, 2014.
G: 21.48 (-0.09)
Nuveen's Bob Doll Runs Several Top Funds
at Investor's Business Daily - Tue Feb 03, 5:22PM CST
Bob Doll runs an all-star team. Five Nuveen Asset Management stock mutual funds he runs rank in the top 130 U.S. diversified stock funds based on trailing 12-month performance through Jan. 31, according to Morningstar Inc. His $100 million...
HII: 125.12 (+1.02), BIIB: 391.66 (-0.45), GD: 137.61 (-0.54), GE: 25.15 (+0.26), LMT: 196.95 (-0.53), G: 21.48 (-0.09), BCR: 175.38 (+0.50), AMGN: 153.48 (+0.30), GLW: 25.00 (+0.14), ANTM: 141.05 (-0.95), GILD: 101.90 (+1.10), GPS: 41.20 (-0.37), MSFT: 43.87 (+0.78), AAPL: 127.08 (+0.62), MA: 87.14 (-0.38)
Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 4:35PM CST
CNW: 45.26 (+1.09), HI: 30.28 (+0.01), PRU: 80.33 (+1.63), BGC: 14.40 (+0.51), ENS: 62.53 (+0.98), ADEP: 6.93 (-0.30), PRE: 119.71 (-0.07), APU: 51.14 (+0.18), FOXA: 34.72 (+0.31), BKD: 37.27 (+0.68), MUSA: 71.09 (-0.44), OSUR: 8.13 (+0.06), MTRX: 19.92 (+0.77), GIL: 59.48 (+0.23), CDNS: 18.02 (+0.10), NXPI: 84.79 (-0.60), LNC: 58.44 (+0.38), ALL: 71.46 (-0.11), LCI: 57.78 (-0.91), HUBG: 39.46 (+0.01), FORM: 8.50 (-0.02), ESS: 226.69 (-1.30), CMRE: 19.60 (+0.30), NE: 18.54 (+0.30), G: 21.48 (-0.09), CLW: 63.20 (-0.74), AFOP: 16.51 (+0.03), GMCR: 118.53 (+0.56), GLUU: 5.12 (+0.14), PAA: 51.48 (+0.16), AWH: 40.50 (-0.19), AFFX: 11.45 (+0.02), ATML: 8.39 (+0.09), PMT: 21.64 (+0.05), CINF: 52.46 (+0.27), P: 15.44 (+0.45), GPRE: 25.50 (-0.56), EPM: 6.70 (+0.07), BDN: 16.45 (-0.17), IRBT: 31.16 (+0.18), ININ: 42.99 (+0.14), CBG: 34.96 (-0.17), BMR: 22.85 (-0.13), GEOS: 19.15 (+0.02), PNNT: 9.40 (+0.16), FBHS: 46.58 (+1.02), MTGE: 18.33 (+0.01), ORLY: 205.55 (-1.02), FMC: 63.68 (+0.44), EXAR: 10.75 (-0.06), CATM: 37.02 (-0.37), ACXM: 19.10 (unch), FEIC: 79.99 (+0.87), PAGP: 27.84 (+0.04), CEB: 79.35 (+0.93), DATA: 99.90 (+1.40), MAC: 85.88 (-1.33), MAA: 73.82 (-0.59)
15.7% Return Seen to Date on SmarTrend Genpact Call (G)
Comtex SmarTrend(R) - Thu Jan 29, 10:00AM CST
SmarTrend identified an Uptrend for Genpact (NYSE:G) on October 31st, 2014 at $17.48. In approximately 3 months, Genpact has returned 15.73% as of today's recent price of $20.23.
G: 21.48 (-0.09)
Technical Analysis: Cisco, Twitter and Genpact
Kumar Abhishek - Amigobulls - Wed Jan 28, 11:00PM CST
Twitter stock price has formed a double top pattern. Cisco stock price is seen forming a head and shoulders pattern. RSI indicates Genpact stock is oversold
G: 21.48 (-0.09), TWTR: 48.50 (+0.55), CSCO: 29.43 (-0.03)
'Mad Money' Lightning Round: Altria's Stock Is Still Good
at The Street - Fri Jan 23, 5:00AM CST
Cramer prefers Constellation Brands over Anheuser-Busch, says Blackstone is the only private equity company worth recommending and thinks Flextronics should be higher.
FLEX: 12.05 (-0.09), BUD: 121.72 (-0.80), G: 21.48 (-0.09), BX: 37.40 (+0.49), STZ: 113.03 (-0.48), MO: 54.76 (-0.78), BMY: 60.04 (+0.56), MNKD: 7.00 (+0.02), CSX: 36.08 (-0.49), UNP: 122.60 (-1.23)
Jim Cramer's 'Mad Money' Recap: Here Are More Reasons to Buy U.S. Stocks
at The Street - Thu Jan 22, 7:26PM CST
Today's rally stemmed from positive actions in Europe but many of the wrong stocks rallied on the news and will be heading lower very soon, Cramer warns.
FLEX: 12.05 (-0.09), BUD: 121.72 (-0.80), CY: 14.76 (+0.01), HAR: 136.40 (-3.18), BX: 37.40 (+0.49), G: 21.48 (-0.09), AXP: 78.08 (-2.40), UNH: 109.44 (-0.40), STZ: 113.03 (-0.48), MO: 54.76 (-0.78), BMY: 60.04 (+0.56), KEY: 14.11 (-0.08), MNKD: 7.00 (+0.02), CSX: 36.08 (-0.49), LUV: 43.30 (-0.20), JNJ: 99.62 (+1.18), IBM: 160.40 (+1.88), UNP: 122.60 (-1.23), URI: 92.98 (+1.41)
Shares of G Up 17.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 22, 10:00AM CST
SmarTrend identified an Uptrend for Genpact (NYSE:G) on October 31st, 2014 at $17.48. In approximately 3 months, Genpact has returned 17.45% as of today's recent price of $20.53.
G: 21.48 (-0.09)
How U.S. Investors Can Play Europe’s Expected Stimulus Plan
at The Street - Wed Jan 21, 1:29PM CST
U.S. investors should buy European financial stocks such as banks and insurers as well as more cyclical sectors like construction and mining, say two Barclays analysts.
G: 21.48 (-0.09), HSBC: 46.13 (-0.01), LYG: 4.60 (+0.04)
Genpact Survey Results: Retail and Commercial Bank COOs Say Firms Can Unleash Over $500 Million A Year Through Advanced Operations
PR Newswire - Thu Jan 15, 8:00AM CST
Genpact Limited (NYSE: G), a global leader in designing, transforming, and running intelligent business process operations, has released findings on how retail and commercial banking executives are tackling critical strategic challenges through operational excellence. These insights come from operations leaders at banks in North America -predominantly large companies with more than 10,000 employees.
G: 21.48 (-0.09)
Genpact Up 14.6% Since SmarTrend Uptrend Call (G)
Comtex SmarTrend(R) - Wed Jan 14, 5:00PM CST
SmarTrend identified an Uptrend for Genpact (NYSE:G) on October 31st, 2014 at $17.48. In approximately 3 months, Genpact has returned 14.65% as of today's recent price of $20.04.
G: 21.48 (-0.09)
Genpact to Host Investor and Analyst Day in New York City on February 27, 2015
PR Newswire - Wed Jan 14, 12:15PM CST
Genpact Limited (NYSE: G), a global leader in designing, transforming, and running intelligent business operations, will host an Investor and Analyst Day on Friday, February 27, 2015 at the New York Hilton Midtown, 1335 Avenue of the Americas in New York City. Registration will begin at 8:00 a.m. and the event concludes at 1:30 p.m.
G: 21.48 (-0.09)
Genpact Survey Results: Insurers Address Enterprise Challenges Using Advanced Operating Models
PR Newswire - Tue Jan 13, 7:00AM CST
Genpact Limited (NYSE: G), a global leader in designing, transforming, and running intelligent business process operations, has released the insurance industry findings excerpted from its survey of 920 senior executives. These insights come from 95 senior executives in the property and casualty (P&C) insurance industry working in predominantly large companies with more than 10,000 employees in North America.
G: 21.48 (-0.09)
Genpact Schedules Earnings Announcement and Conference Call for Fourth Quarter and 2014 Year-End Results
PR Newswire - Fri Jan 09, 9:30AM CST
Genpact Limited (NYSE: G), a global leader in designing, transforming, and running intelligent business operations, will announce results for the fourth quarter and full year ended December 31, 2014 after market close on Wednesday, February 4.
G: 21.48 (-0.09)
Survey Results: Life Sciences Leadership Says Advanced Operating Models Can Generate a Billion Dollars of Impact Annually
PR Newswire - Wed Dec 17, 9:00AM CST
Genpact Limited (NYSE: G), a global leader in designing, transforming, and running intelligent business process operations, has released the life sciences industry findings excerpted from its survey of 920 senior executives. These life sciences insights come from 233 senior executives in the life sciences industry and primarily based on the responses of 120 respondents engaged in R&D and 69 in commercial operations, respectively. The majority of these executives come from large companies with North American operations with more than 10,000 employees.
G: 21.48 (-0.09)